Clinical Trial

The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women With Obesity

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The purpose of this study is to determine the effect of tirzepatide on vasomotor symptoms and on measures of biological aging.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-10-16; most recent amendment 2026-06-03.
Status change: Active, Not Recruiting → Recruiting 2026-03-20
Trial Details
NCT Number NCT07218445
Lead Sponsor Mayo Clinic
Conditions Obesity, Menopause Hot Flashes
Enrollment 40 participants
Start Date 2026-04-08
Primary Completion 2027-09-18 (estimated)
Study Completion 2027-09-18 (estimated)
Updated on ClinicalTrials.gov 2026-06-05